Literature DB >> 26797136

Imaging Findings Associated with Space-Occupying Edema in Patients with Large Middle Cerebral Artery Infarcts.

A D Horsch1, J W Dankbaar2, T A Stemerdink2, E Bennink2, T van Seeters2, L J Kappelle3, J Hofmeijer4, H W de Jong2, Y van der Graaf5, B K Velthuis2.   

Abstract

BACKGROUND AND
PURPOSE: Prominent space-occupying cerebral edema is a devastating complication occurring in some but not all patients with large MCA infarcts. It is unclear why differences in the extent of edema exist. Better knowledge of factors related to prominent edema formation could aid treatment strategies. This study aimed to identify variables associated with the development of prominent edema in patients with large MCA infarcts.
MATERIALS AND METHODS: From the Dutch Acute Stroke Study (DUST), 137 patients were selected with large MCA infarcts on follow-up NCCT (3 ± 2 days after stroke onset), defined as ASPECTS ≤4. Prominent edema was defined as a midline shift of ≥5 mm on follow-up. Admission patient and treatment characteristics were collected. Admission CT parameters used were ASPECTS on NCCT and CBV and MTT maps, and occlusion site, clot burden, and collaterals on CTA. Permeability on admission CTP, and day 3 recanalization and reperfusion statuses were obtained if available. Unadjusted and adjusted (age and NIHSS) odds ratios were calculated for all variables in relation to prominent edema.
RESULTS: Prominent edema developed in 51 patients (37%). Adjusted odds ratios for prominent edema were higher with lower ASPECTS on NCCT (adjusted odds ratio, 1.32; 95% CI, 1.13-1.55) and CBV (adjusted odds ratio, 1.26; 95% CI, 1.07-1.49), higher permeability (adjusted odds ratio, 2.35; 95% CI, 1.30-4.24), more proximal thrombus location (adjusted odds ratio, 3.40; 95% CI, 1.57-7.37), higher clot burden (adjusted odds ratio, 2.88; 95% CI, 1.11-7.45), and poor collaterals (adjusted odds ratio, 3.93; 95% CI, 1.78-8.69).
CONCLUSIONS: Extensive proximal occlusion, poor collaterals, and larger ischemic deficits with higher permeability play a role in the development of prominent edema in large MCA infarcts.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2016        PMID: 26797136      PMCID: PMC7960291          DOI: 10.3174/ajnr.A4637

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

1.  The severity of ischemia determines and predicts malignant brain edema in patients with large middle cerebral artery infarction.

Authors:  Christian Dohmen; Norbert Galldiks; Bert Bosche; Lutz Kracht; Rudolf Graf
Journal:  Cerebrovasc Dis       Date:  2011-11-30       Impact factor: 2.762

2.  Outcomes in severe middle cerebral artery ischemic stroke.

Authors:  Brian P Walcott; Jennifer C Miller; Churl-Su Kwon; Sameer A Sheth; Marc Hiller; Carolyn A Cronin; Lee H Schwamm; J Marc Simard; Kristopher T Kahle; W Taylor Kimberly; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

3.  A fast nonlinear regression method for estimating permeability in CT perfusion imaging.

Authors:  Edwin Bennink; Alan J Riordan; Alexander D Horsch; Jan Willem Dankbaar; Birgitta K Velthuis; Hugo W de Jong
Journal:  J Cereb Blood Flow Metab       Date:  2013-07-24       Impact factor: 6.200

4.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.

Authors:  P A Barber; A M Demchuk; J Zhang; A M Buchan
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

5.  Increased blood-brain barrier permeability on perfusion CT might predict malignant middle cerebral artery infarction.

Authors:  Hesna Bektas; Tzu-Ching Wu; Mallikarjunarao Kasam; Nusrat Harun; Clark W Sitton; James C Grotta; Sean I Savitz
Journal:  Stroke       Date:  2010-09-16       Impact factor: 7.914

6.  Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction.

Authors:  Christian Dohmen; Bert Bosche; Rudolf Graf; Thomas Reithmeier; Ralf-Ingo Ernestus; Gerrit Brinker; Jan Sobesky; Wolf-Dieter Heiss
Journal:  Stroke       Date:  2006-11-22       Impact factor: 7.914

Review 7.  Malignant middle cerebral artery infarction.

Authors:  Katja E Wartenberg
Journal:  Curr Opin Crit Care       Date:  2012-04       Impact factor: 3.687

8.  Incidence of space-occupying brain edema following systemic thrombolysis of acute supratentorial ischemia.

Authors:  J Rudolf; M Grond; C Stenzel; M Neveling; W D Heiss
Journal:  Cerebrovasc Dis       Date:  1998 May-Jun       Impact factor: 2.762

9.  Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial.

Authors:  Jeannette Hofmeijer; L Jaap Kappelle; Ale Algra; G Johan Amelink; Jan van Gijn; H Bart van der Worp
Journal:  Lancet Neurol       Date:  2009-03-05       Impact factor: 44.182

10.  Prediction of outcome in patients with suspected acute ischaemic stroke with CT perfusion and CT angiography: the Dutch acute stroke trial (DUST) study protocol.

Authors:  Tom van Seeters; Geert Jan Biessels; Irene C van der Schaaf; Jan Willem Dankbaar; Alexander D Horsch; Merel J A Luitse; Joris M Niesten; Willem P T M Mali; L Jaap Kappelle; Yolanda van der Graaf; Birgitta K Velthuis
Journal:  BMC Neurol       Date:  2014-02-25       Impact factor: 2.474

View more
  7 in total

1.  Crossed cerebellar diaschisis in acute ischemic stroke: Impact on morphologic and functional outcome.

Authors:  Wolfgang G Kunz; Wieland H Sommer; Christopher Höhne; Matthias P Fabritius; Felix Schuler; Franziska Dorn; Ahmed E Othman; Felix G Meinel; Louisa von Baumgarten; Maximilian F Reiser; Birgit Ertl-Wagner; Kolja M Thierfelder
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-13       Impact factor: 6.200

2.  Association of Reperfusion With Brain Edema in Patients With Acute Ischemic Stroke: A Secondary Analysis of the MR CLEAN Trial.

Authors:  W Taylor Kimberly; Bruna Garbugio Dutra; Anna M M Boers; Heitor C B R Alves; Olvert A Berkhemer; Lucie van den Berg; Kevin N Sheth; Yvo B W E M Roos; Aad van der Lugt; Ludo F M Beenen; Diederik W J Dippel; Wim H van Zwam; Robert J van Oostenbrugge; Hester F Lingsma; Henk Marquering; Charles B L M Majoie
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

3.  Quantitative Serial CT Imaging-Derived Features Improve Prediction of Malignant Cerebral Edema after Ischemic Stroke.

Authors:  Hossein Mohammadian Foroushani; Ali Hamzehloo; Atul Kumar; Yasheng Chen; Laura Heitsch; Agnieszka Slowik; Daniel Strbian; Jin-Moo Lee; Daniel S Marcus; Rajat Dhar
Journal:  Neurocrit Care       Date:  2020-07-29       Impact factor: 3.210

4.  Intracranial Cerebrospinal Fluid Volume as a Predictor of Malignant Middle Cerebral Artery Infarction.

Authors:  Frans Kauw; Edwin Bennink; Hugo W A M de Jong; L Jaap Kappelle; Alexander D Horsch; Birgitta K Velthuis; Jan W Dankbaar
Journal:  Stroke       Date:  2019-05-16       Impact factor: 7.914

5.  Incremental Value of Computed Tomography Perfusion for Final Infarct Prediction in Acute Ischemic Cerebellar Stroke.

Authors:  Matthias P Fabritius; Paul Reidler; Matthias F Froelich; Lukas T Rotkopf; Thomas Liebig; Lars Kellert; Katharina Feil; Steffen Tiedt; Philipp M Kazmierczak; Kolja M Thierfelder; Daniel Puhr-Westerheide; Wolfgang G Kunz
Journal:  J Am Heart Assoc       Date:  2019-10-19       Impact factor: 5.501

6.  A Dynamic Nomogram for 3-Month Prognosis for Acute Ischemic Stroke Patients After Endovascular Therapy: A Pooled Analysis in Southern China.

Authors:  Zhi-Xin Huang; Yong-Kun Li; Shi-Zhan Li; Xian-Jun Huang; Ying Chen; Quan-Long Hong; Qian-Kun Cai; Yun-Fei Han
Journal:  Front Aging Neurosci       Date:  2021-12-13       Impact factor: 5.750

Review 7.  Role of Decompressive Craniectomy in Ischemic Stroke.

Authors:  Lars-Peder Pallesen; Kristian Barlinn; Volker Puetz
Journal:  Front Neurol       Date:  2019-01-09       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.